TIPIN depletion leads to apoptosis in breast cancer cells

Archive ouverte

Baldeyron, Céline | Brisson, Amélie | Tesson, Bruno | Nemati, Fariba | Koundrioukoff, Stéphane | Saliba, Elie | de Koning, Leanne | Martel, Elise | Ye, Mengliang | Rigaill, Guillem | Meseure, Didier | Nicolas, André | Gentien, David | Decaudin, Didier | Debatisse, Michelle | Depil, Stephane | Cruzalegui, Francisco | Pierré, Alain | Roman-Roman, Sergio | Tucker, Gordon C | Dubois, Thierry

Edité par CCSD ; FEBS Press -

International audience. Triple-negative breast cancer (TNBC) is the breast cancer subgroup with the most aggressive clinical behavior. Alternatives to conventional chemotherapy are required to improve the survival of TNBC patients. Gene-expression analyses for different breast cancer subtypes revealed significant overexpression of the Timeless-interacting protein (TIPIN), which is involved in the stability of DNA replication forks, in the highly proliferative associated TNBC samples. Immunohistochemistry analysis showed higher expression of TIPIN in the most proliferative and aggressive breast cancer subtypes including TNBC, and no TIPIN expression in healthy breast tissues. The depletion of TIPIN by RNA interference impairs the proliferation of both human breast cancer and non-tumorigenic cell lines. However, this effect may be specifically associated with apoptosis in breast cancer cells. TIPIN silencing results in higher levels of single-stranded DNA (ssDNA), indicative of replicative stress (RS), in TNBC compared to non-tumorigenic cells. Upon TIPIN depletion, the speed of DNA replication fork was significantly decreased in all BC cells. However, TIPIN-depleted TNBC cells are unable to fire additional replication origins in response to RS and therefore undergo apoptosis. TIPIN knockdown in TNBC cells decreases tumorigenicity in vitro and delays tumor growth in vivo. Our findings suggest that TIPIN is important for the maintenance of DNA replication and represents a potential treatment target for the worst prognosis associated breast cancers, such as TNBC.

Consulter en ligne

Suggestions

Du même auteur

Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer

Archive ouverte | Maire, Virginie | CCSD

Breast cancers are composed of molecularly distinct subtypes with different clinical outcomes and responses to therapy. To discover potential therapeutic targets for the poor prognosis-associated triple-negative breast cancer (TNB...

PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer

Archive ouverte | Suresh, Samyuktha | CCSD

International audience. Identifying new therapeutic strategies for triple-negative breast cancer (TNBC) patients is a priority as these patients are highly prone to relapse after chemotherapy. Here, we found that pr...

Protein arginine methyltransferase 5: A novel therapeutic target for triple-negative breast cancers

Archive ouverte | Vinet, Mathilde | CCSD

International audience. TNBC is a highly heterogeneous and aggressive breast cancer subtype associated with high relapse rates, and for which no targeted therapy yet exists. Protein arginine methyltransferase 5 (PRM...

Chargement des enrichissements...